IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma

Shanshan Chen(Chongqing University of Posts and Telecommunications), Yang Sun(Fujian Medical University)
Clinical and Experimental Medicine
August 28, 2024
Cited by 15


Related Papers